Recruiting
Safety, Tolerability, and PK of AH-008 Following Single Ascending Dose in Healthy Subjects
NCT07697560
- Conditions
- Chemotherapy-induced Peripheral Neuropathy (CIPN)
- Locations
-
- ICON Clinial Research Unit Salt Lake City, Utah, United States